Signaling involved in pituitary adenylate cyclase-activating polypeptide-stimulated ADNP expression

Tomoya Nakamachi, Min Li, Seiji Shioda, Akira Arimura*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

Activity-dependent neurotrophic protein (ADNP) was discovered as a novel response gene for VIP and has neuroprotective potential. When the VIP paralog, PACAP38 was added to mouse neuron-glia co-cultures, it induced ADNP mRNA expression in a bimodal fashion at subpico- and nanomolar concentrations with greater response at subpicomolar level. The response was attenuated by a PAC1-R antagonist at both concentrations and by a VPAC1-R antagonist at nanomolar concentration only. An IP3/PLC inhibitor attenuated the response at both concentrations of PACAP38, but a MAPK inhibitor had no effect. A PKA inhibitor suppressed the response at nanomolar concentration only. These findings suggest that ADNP expression is mediated through multiple receptors and signaling pathways that are regulated by different concentrations of PACAP.

Original languageEnglish
Pages (from-to)1859-1864
Number of pages6
JournalPeptides
Volume27
Issue number7
DOIs
StatePublished - 2006/07

Keywords

  • ADNP
  • Mouse
  • Neuron/glia co-culture
  • PACAP
  • Signal transduction

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Endocrinology
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Signaling involved in pituitary adenylate cyclase-activating polypeptide-stimulated ADNP expression'. Together they form a unique fingerprint.

Cite this